Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: Alpine Immune Sciences (2) Acquired (2)
alpn-101 (3 trials)
cavosonstat (7 trials)
danegaptide (1 trial)
Povetacicept (3 trials)
Key: Alpine Immune Sciences (2) Acquired (3)
alpn-202 (2 trials)
n6022 (3 trials)
pembrolizumab (keytruda) (1 trial)
rifampin (1 trial)
sodium chloride (1 trial)
Graft vs Host Disease (Phase 1)
Neoplasms (Phase 1)
Trials (19 total)
Trial APIs (9 total)